Intersection of Chronic Pain Treatment and Opioid Analgesic Misuse: Causes, Treatments, and Policy Strategies

Overview

Journal Subst Abuse Rehabil

Publisher Dove Medical Press

Specialty Psychiatry

Date 2014 Jan 30

PMID 24474854

Citations 8

Authors

Amy Wachholtz

Gerardo Gonzalez

Edward Boyer

Zafar N Naqvi

Christopher Rosenbaum

Douglas Ziedonis

Affiliations

Soon will be listed here.

Abstract

Treating chronic pain in the context of opioid misuse can be very challenging. This paper explores the epidemiology and potential treatments for chronic pain and opioid misuse and identifies educational and regulation changes that may reduce diversion of opioid analgesics. We cover the epidemiology of chronic pain and aberrant opioid behaviors, psychosocial influences on pain, pharmacological treatments, psychological treatments, and social treatments, as well as educational and regulatory efforts being made to reduce the diversion of prescription opioids. There are a number of ongoing challenges in treating chronic pain and opioid misuse, and more research is needed to provide strong, integrated, and empirically validated treatments to reduce opioid misuse in the context of chronic pain.

Citing Articles

Primary care and medication management characteristics among patients receiving office-based opioid treatment with buprenorphine.

Xinxin Du C, Shi J, Tetrault J, Madden L, Barry D Fam Pract. 2021; 39(2):234-240.

PMID: 34893825 PMC: 8947790. DOI: 10.1093/fampra/cmab166.

Psycho-physiological response to pain among individuals with comorbid pain and opioid use disorder: Implications for patients with prolonged abstinence.

Wachholtz A, Gonzalez G, Ziedonis D Am J Drug Alcohol Abuse. 2019; 45(5):495-505.

PMID: 31246117 PMC: 6684104. DOI: 10.1080/00952990.2019.1620260.

An evaluation of the feasibility, acceptability, and preliminary efficacy of cognitive-behavioral therapy for opioid use disorder and chronic pain.

Barry D, Beitel M, Cutter C, Fiellin D, Kerns R, Moore B Drug Alcohol Depend. 2018; 194:460-467.

PMID: 30508769 PMC: 6312460. DOI: 10.1016/j.drugalcdep.2018.10.015.

Risk factors for addiction among patients receiving prescribed opioids: a systematic review protocol.

Cragg A, Hau J, Woo S, Liu C, Doyle-Waters M, Hohl C Syst Rev. 2017; 6(1):265.

PMID: 29282114 PMC: 5746013. DOI: 10.1186/s13643-017-0642-0.

Pseudoaddiction: Fact or Fiction? An Investigation of the Medical Literature.

Greene M, Chambers R Curr Addict Rep. 2015; 2(4):310-317.

PMID: 26550549 PMC: 4628053. DOI: 10.1007/s40429-015-0074-7.

References

Turk D, Okifuji A . Psychological factors in chronic pain: evolution and revolution. J Consult Clin Psychol. 2002; 70(3):678-90. DOI: 10.1037//0022-006x.70.3.678. View

Mattick R, Breen C, Kimber J, Davoli M . Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2003; (2):CD002209. DOI: 10.1002/14651858.CD002209. View

Arnold L, Lu Y, Crofford L, Wohlreich M, Detke M, Iyengar S . A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004; 50(9):2974-84. DOI: 10.1002/art.20485. View

Crofford L, Mease P, Simpson S, Young Jr J, Martin S, Haig G . Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain. 2008; 136(3):419-431. DOI: 10.1016/j.pain.2008.02.027. View

Chevillard L, Megarbane B, Baud F, Risede P, Decleves X, Mager D . Mechanisms of respiratory insufficiency induced by methadone overdose in rats. Addict Biol. 2009; 15(1):62-80. DOI: 10.1111/j.1369-1600.2009.00184.x. View

Furlan A, Sandoval J, Mailis-Gagnon A, Tunks E . Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006; 174(11):1589-94. PMC: 1459894. DOI: 10.1503/cmaj.051528. View

Mathew N, Kurman R, Perez F . Drug induced refractory headache--clinical features and management. Headache. 1990; 30(10):634-8. DOI: 10.1111/j.1526-4610.1990.hed3010634.x. View

Cooper J . Including narcotic addiction treatment in an office-based practice. JAMA. 1995; 273(20):1619-20. View

Graham N, Merlo L, Goldberger B, Gold M . Methadone- and heroin-related deaths in Florida. Am J Drug Alcohol Abuse. 2008; 34(3):347-53. DOI: 10.1080/00952990802010892. View

10.

Fishbain D, Cole B, Lewis J, Rosomoff H, Steele Rosomoff R . What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med. 2008; 9(4):444-59. DOI: 10.1111/j.1526-4637.2007.00370.x. View

11.

Joranson D, Ryan K, Gilson A, Dahl J . Trends in medical use and abuse of opioid analgesics. JAMA. 2001; 283(13):1710-4. DOI: 10.1001/jama.283.13.1710. View

12.

Larson M, Paasche-Orlow M, Cheng D, Lloyd-Travaglini C, Saitz R, Samet J . Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. Addiction. 2007; 102(5):752-60. DOI: 10.1111/j.1360-0443.2007.01759.x. View

13.

Vadivelu N, Mitra S, Hines R . Peripheral opioid receptor agonists for analgesia: a comprehensive review. J Opioid Manag. 2011; 7(1):55-68. DOI: 10.5055/jom.2011.0049. View

14.

Kirchheiner J, Schmidt H, Tzvetkov M, Keulen J, Lotsch J, Roots I . Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Pharmacogenomics J. 2006; 7(4):257-65. DOI: 10.1038/sj.tpj.6500406. View

15.

Johnson R, Fudala P, Payne R . Buprenorphine: considerations for pain management. J Pain Symptom Manage. 2005; 29(3):297-326. DOI: 10.1016/j.jpainsymman.2004.07.005. View

16.

Ives T, Chelminski P, Hammett-Stabler C, Malone R, Perhac J, Potisek N . Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006; 6:46. PMC: 1513222. DOI: 10.1186/1472-6963-6-46. View

17.

Folkesson A, Honore P, Andersen L, Kristensen P, Bjerrum O . Low dose of donepezil improves gabapentin analgesia in the rat spared nerve injury model of neuropathic pain: single and multiple dosing studies. J Neural Transm (Vienna). 2010; 117(12):1377-85. DOI: 10.1007/s00702-010-0494-4. View

18.

Schappert S . National Ambulatory Medical Care Survey: 1989 summary. Vital Health Stat 13. 1992; (110):1-80. View

19.

Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy R . Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003; 289(18):2370-8. DOI: 10.1001/jama.289.18.2370. View

20.

Brodner R, Taub A . Chronic pain exacerbated by long-term narcotic use in patients with nonmalignant disease: clinical syndrome and treatment. Mt Sinai J Med. 1978; 45(2):233-7. View